FDA NDC Directory · JSON-LD · Markdown

ENTYVIO

NDC 64764-107 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namevedolizumab
Labeler / ManufacturerTakeda Pharmaceuticals America, Inc.
Marketing categoryBiologic License Application · App BLA761133
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsVEDOLIZUMAB (108 mg/.68mL)
Marketing started20230927
Package count1

External sources

Source: openFDA. Public-domain (CC0).